# clm_3F78C327F519

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: quarterly_operating_income  
value: 591,700,000 United States dollar  
valid_from: 2025-03-31  
valid_to: 2025-06-30  
published: 2025-04-29  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_0CA4006DEF0C  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals quarterly operating income: 591,700,000 United States dollar", as of 2025-03-31 (until 2025-06-30). Claim clm_3F78C327F519, https://asof.is/claim/clm_3F78C327F519, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:OperatingIncomeLoss in 10-Q Q1 FY2025, filed 2025-04-29  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000180422025000022/0001804220-25-000022-index.htm (primary, SEC EDGAR 10-Q Q1 FY2025, published 2025-04-29)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | quarterly_operating_income | 1,179,500,000 United States dollar | valid 2024-09-30 to 2025-03-31 | conf 0.95 | superseded | superseded_by [clm_3F78C327F519](/claim/clm_3F78C327F519.md) | [clm_EB508637D538](/claim/clm_EB508637D538.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.